One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Open Accesshttps://doi.org/10.1136/jitc-2021-003508
Copy DOI Journal: Journal for ImmunoTherapy of Cancer |  Publication Date: Apr 1, 2022 |
 Citations: 10 |  License type: open-access |
Affiliation: Hôpital Albert-Chenevier, Inserm, Mondor Institute of Biomedical Research, Université Paris-Est Créteil, Pitié-Salpêtrière Hospital, Sorbonne Université, Hôpital Saint-Louis, Centre d'Immunologie et des Maladies Infectieuses, French National Centre for Scientific Research, University of OxfordBackgroundTargeting immune checkpoints that inhibit antitumor immune responses has emerged as a powerful new approach to treat cancer. We recently showed that blocking the tumor necrosis factor receptor-type 2 (TNFR2)...
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
